+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07646977

Study of Coronary Thrombus Modification Versus Standard Stent Implantation to Reduce Microvascular Damage in STEMI Patients

Led by Odense University Hospital · Updated on 2026-09-02

100

Participants Needed

1

Research Sites

252 weeks

Total Duration

AI-Summary

What This Trial Is About

This trial focuses on patients with ST-Elevation Myocardial Infarction STEMI undergoing primary percutaneous coronary intervention PCI. It aims to assess how modifying the coronary thrombus might reduce microvascular damage and limit heart muscle injury, measured by the myocardial salvage index after three months. The study also investigates coronary microvascular damage using invasive thermodilution methods before and after stent placement, and explores how pre-stenting physiological measurements relate to cardiac magnetic resonance imaging results. Participants will be randomly assigned to one of two groups coronary thrombus modification or standard stent implantation. The modification involves inflating a balloon briefly and repeatedly to alter the thrombus before stenting, while the control group receives standard stenting as usual. Physiological assessments using continuous and bolus thermodilution will be done before and after the intervention. Cardiac magnetic resonance imaging will be performed before hospital discharge and again three months later to evaluate heart muscle damage and function. During the study, participants will have detailed heart function tests, including invasive pressure and flow measurements and imaging scans to assess heart muscle salvage and damage. Follow-up will collect clinical outcomes such as death, heart attacks, repeat procedures, and hospitalizations for heart failure at 12 months, 24 months, and five years. The main outcome is the myocardial salvage index at three months, with additional measures from imaging and physiology evaluated at several time points. Participants are involved for at least three months with longer-term monitoring via medical records.

CONDITIONS

Brief Title

CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here